BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38504503)

  • 1. Drug reactive metabolite-induced hepatotoxicity: a comprehensive review.
    Mahajan P; Palkar M; Pingili RB
    Toxicol Mech Methods; 2024 Jul; 34(6):607-627. PubMed ID: 38504503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.
    Giri S; Nieber K; Bader A
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):895-917. PubMed ID: 20367107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity.
    Khalil SM; MacKenzie KR; Maletic-Savatic M; Li F
    Drug Metab Rev; 2024; 56(2):97-126. PubMed ID: 38311829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reactive metabolites of xenobiotics : their role in the hepatotoxicity of drugs].
    Pessayre D; Benhamou JP
    C R Seances Soc Biol Fil; 1979; 173(2):458-68. PubMed ID: 159767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of metabolism in drug-induced idiosyncratic hepatotoxicity.
    Walgren JL; Mitchell MD; Thompson DC
    Crit Rev Toxicol; 2005; 35(4):325-61. PubMed ID: 15989140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of potential hepatotoxicity induced by drugs.
    Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
    Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of reactive metabolites in drug-induced hepatotoxicity.
    Srivastava A; Maggs JL; Antoine DJ; Williams DP; Smith DA; Park BK
    Handb Exp Pharmacol; 2010; (196):165-94. PubMed ID: 20020263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: drug-induced hepatotoxicity.
    Lee WM
    Aliment Pharmacol Ther; 1993 Oct; 7(5):477-85. PubMed ID: 8280816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-Based Inhibitors from Phytomedicine: Risks of Hepatotoxicity and their Potential Hepatotoxic Substructures.
    Wang L; He X; Jin C; Ondieki G
    Curr Drug Metab; 2016; 17(10):971-991. PubMed ID: 27890005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In Vitro and in Vivo Assessments of Drug-induced Hepatotoxicity and Drug Metabolism in Humans].
    Sanoh S
    Yakugaku Zasshi; 2015; 135(11):1273-9. PubMed ID: 26521876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450.
    Brewer CT; Chen T
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of metabolic activation in drug-induced hepatotoxicity.
    Park BK; Kitteringham NR; Maggs JL; Pirmohamed M; Williams DP
    Annu Rev Pharmacol Toxicol; 2005; 45():177-202. PubMed ID: 15822174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug damage to the liver: role of reactive metabolites and pharmacokinetics].
    Lauterburg BH
    Schweiz Med Wochenschr; 1985 Sep; 115(38):1306-12. PubMed ID: 3933110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug metabolite profiling and elucidation of drug-induced hepatotoxicity.
    Tang W
    Expert Opin Drug Metab Toxicol; 2007 Jun; 3(3):407-20. PubMed ID: 17539747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity.
    Feng S; He X
    Curr Drug Metab; 2013 Nov; 14(9):921-45. PubMed ID: 24016115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.
    Prandota J
    Am J Ther; 2005; 12(3):254-61. PubMed ID: 15891270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dictamnine-induced hepatotoxicity in mice: the role of metabolic activation of furan.
    Shi F; Pan H; Cui B; Li Y; Huang L; Lu Y
    Toxicol Appl Pharmacol; 2019 Feb; 364():68-76. PubMed ID: 30578885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effects of Essential Oils as Natural Antioxidants against Hepatotoxicity Induced by Cyclophosphamide in Mice.
    Sheweita SA; El-Hosseiny LS; Nashashibi MA
    PLoS One; 2016; 11(11):e0165667. PubMed ID: 27802299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Sakatis MZ; Reese MJ; Harrell AW; Taylor MA; Baines IA; Chen L; Bloomer JC; Yang EY; Ellens HM; Ambroso JL; Lovatt CA; Ayrton AD; Clarke SE
    Chem Res Toxicol; 2012 Oct; 25(10):2067-82. PubMed ID: 22931300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.